Cargando…

The Swedish MS registry – clinical support tool and scientific resource

The Swedish MS registry (SMSreg) is designed to assure quality health care for patients with multiple sclerosis (MS). It has been active since 2001 and web-based since 2004. It runs on government funding only and is used in all Swedish neurology departments. The SMSreg currently includes data on 14,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillert, J, Stawiarz, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657484/
https://www.ncbi.nlm.nih.gov/pubmed/26046553
http://dx.doi.org/10.1111/ane.12425
_version_ 1782402402041724928
author Hillert, J
Stawiarz, L
author_facet Hillert, J
Stawiarz, L
author_sort Hillert, J
collection PubMed
description The Swedish MS registry (SMSreg) is designed to assure quality health care for patients with multiple sclerosis (MS). It has been active since 2001 and web-based since 2004. It runs on government funding only and is used in all Swedish neurology departments. The SMSreg currently includes data on 14,500 of Sweden's estimated 17,500 prevalent patients with MS. One important function of SMSreg, to which participation is voluntary, is to serve as a tool for decision support and to provide an easy overview of the patient information needed at clinical visits. This is its core feature and explains why the majority of Swedish MS specialists contribute data. Another success factor for SMSreg is that entered data can be readily accessed, either through a query function into Excel format or through a set of predesigned tables and diagrams in which parameters can be selected. Recent development includes a portal allowing patients to view a summary of their registered data and to report a set of patient-reported outcomes. SMSreg data have been used in close to 100 published scientific reports. Current projects include an incidence cohort (EIMS), post-marketing cohorts of patients on novel disease-modifying drugs (IMSE), and a prevalence cohort (GEMS). As these studies combine physical sampling and questionnaire data with clinical documentation and possible linkage to other public registries, together they provide an excellent platform for integrated MS research.
format Online
Article
Text
id pubmed-4657484
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46574842015-12-02 The Swedish MS registry – clinical support tool and scientific resource Hillert, J Stawiarz, L Acta Neurol Scand Nordic Ms Epidemiology. Sponsored by an Unrestricted Educational Grant From Teva Nordic. Teva Had No Editorial Input in the Review Process The Swedish MS registry (SMSreg) is designed to assure quality health care for patients with multiple sclerosis (MS). It has been active since 2001 and web-based since 2004. It runs on government funding only and is used in all Swedish neurology departments. The SMSreg currently includes data on 14,500 of Sweden's estimated 17,500 prevalent patients with MS. One important function of SMSreg, to which participation is voluntary, is to serve as a tool for decision support and to provide an easy overview of the patient information needed at clinical visits. This is its core feature and explains why the majority of Swedish MS specialists contribute data. Another success factor for SMSreg is that entered data can be readily accessed, either through a query function into Excel format or through a set of predesigned tables and diagrams in which parameters can be selected. Recent development includes a portal allowing patients to view a summary of their registered data and to report a set of patient-reported outcomes. SMSreg data have been used in close to 100 published scientific reports. Current projects include an incidence cohort (EIMS), post-marketing cohorts of patients on novel disease-modifying drugs (IMSE), and a prevalence cohort (GEMS). As these studies combine physical sampling and questionnaire data with clinical documentation and possible linkage to other public registries, together they provide an excellent platform for integrated MS research. John Wiley & Sons, Ltd 2015-07 2015-06-05 /pmc/articles/PMC4657484/ /pubmed/26046553 http://dx.doi.org/10.1111/ane.12425 Text en Copyright © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Nordic Ms Epidemiology. Sponsored by an Unrestricted Educational Grant From Teva Nordic. Teva Had No Editorial Input in the Review Process
Hillert, J
Stawiarz, L
The Swedish MS registry – clinical support tool and scientific resource
title The Swedish MS registry – clinical support tool and scientific resource
title_full The Swedish MS registry – clinical support tool and scientific resource
title_fullStr The Swedish MS registry – clinical support tool and scientific resource
title_full_unstemmed The Swedish MS registry – clinical support tool and scientific resource
title_short The Swedish MS registry – clinical support tool and scientific resource
title_sort swedish ms registry – clinical support tool and scientific resource
topic Nordic Ms Epidemiology. Sponsored by an Unrestricted Educational Grant From Teva Nordic. Teva Had No Editorial Input in the Review Process
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657484/
https://www.ncbi.nlm.nih.gov/pubmed/26046553
http://dx.doi.org/10.1111/ane.12425
work_keys_str_mv AT hillertj theswedishmsregistryclinicalsupporttoolandscientificresource
AT stawiarzl theswedishmsregistryclinicalsupporttoolandscientificresource
AT hillertj swedishmsregistryclinicalsupporttoolandscientificresource
AT stawiarzl swedishmsregistryclinicalsupporttoolandscientificresource